Salt Lake City, UT, Aug. 18, 2017 -- SALT LAKE CITY, August 21, 2017 /PRNewswire/--ARUP Laboratories and IllumiCare have announced a strategic collaboration to provide clinicians with content and decision support.
|
|||||
In an era of rising patient deductibles and health insurance premiums, it is ever more important to spend healthcare dollars efficiently. Physicians are being asked to provide “value-based care,” yet they are not routinely told what things cost.
“ARUP has long been an advocate of empowering clinicians with current testing knowledge and providing unparalleled guidance through ARUP’s utilization management services,” says Andrew Fletcher, MD, the ARUP medical director of Consultative Services. “We are excited to share the research and expertise of our 90+ medical directors.”
IllumiCare’s Smart Ribbon is a non-intrusive ribbon of information that hovers over or embeds within the electronic medical record and provides real-time visibility of the cumulative risk and financial impact of tests and medications being ordered during the course of care. Studies show that displaying cost and risk of patient harm at the point of care causes physicians to provide safer and more efficient care.
“This partnership allows us to bring the expertise and best practice recommendations of a leading national reference laboratory to physicians at the point of care,” says G.T. LaBorde, CEO of IllumiCare. “Clinicians are being asked to remove waste and provide better care at a lower cost. The Smart Ribbon, with ARUP, provides valuable content for informed decision making, helping to reduce clinical and cost variation during the treatment of care.”
IllumiCare and ARUP together recognize that behind each lab test is a patient that may experience discomfort and a risk of harm. This collaboration seeks to ensure that patients receive the right test at the right time.
Media Contacts:
Cyndee Holden, (801) 583-2787, ext. 3318, [email protected]
G.T. LaBorde, (205) 719-8595, [email protected]
About ARUP Laboratories
Founded in 1984, ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation's top university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®. ARUP is ISO 15189 CAP accredited.
About IllumiCare
Founded in 2014, IllumiCare displays clinical, financial, and patient safety data in a non-intrusive, EMR agnostic “ribbon.” The data displayed can be customized by facility, care setting, user type, and patient type. Cost transparency, predictive analytics, population health and other analytics are powerful tools. They are most effective when provided to your clinicians in real-time, at the point of care.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/86603cd9-a1e7-4efb-8ae8-27579dc70b74
Catherine Arnold ARUP Laboratories (801) 583-2787, ext. 3635 [email protected]


NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services
Tesla Launches New Model Y Variant in the US Starting at $41,990
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 



